Enhancing oncolytic virus efficiency with methionine and <i>N</i>-(3-aminoprolil)methacrylamide modified acrylamide cationic block polymer-Reference-Cited by-同舟云学术

Enhancing oncolytic virus efficiency with methionine and N-(3-aminoprolil)methacrylamide modified acrylamide cationic block polymer

Published:2024 Issue:15 Volume:12 Page:3741-3750
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Chen Gong¹,Yuan Yuan²³⁴,Li Ying²³,He Qianyuan¹,Qin Zizhen⁵,Hu Han¹,Gao Congcong¹,Xu Zushun¹^ORCID,Xu Qi¹,Gao Qinglei²³,Li Fei²³

Affiliation:

1. Ministry of Education Key Laboratory for the Green Preparation and Application of Functional Materials, Hubei Key Laboratory of Polymer Materials, Hubei Collaborative Innovation Center for Advanced Organic Chemical Materials, School of Materials Science and Engineering, Hubei University, Wuhan 430062, China

2. Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430034, China

3. National Clinical Research Centre for Obstetrics and Gynecology, Cancer Biology Research Centre (Key Laboratory of the Ministry of Education), Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430034, China

4. Cancer Center, Renmin Hospital of Wuhan University, Wuhan 430060, China

5. Key laboratory of Biorheological Science and Technology, Ministry of Educations, Collage of Bioengineering, Chongqing University, Chongqing, 40044, China

Abstract

Schematic illustration of the preparation of NAD/Ad complex and the working mechanism for cancer therapy.

Funder

Data Center of Management Science, National Natural Science Foundation of China - Peking University

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/TB/D3TB03016D

Reference44 articles.

1. Oncolytic virotherapy: Molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses

2. Oncolytic virus therapy for malignant gliomas: entering the new era

3. Therapy with oncolytic viruses: progress and challenges

4. Rational selection of an ideal oncolytic virus to address current limitations in clinical translation

5. Oncolytic Viruses for Cancer Therapy: Barriers and Recent Advances